27 November 2021 : Database Analysis
Identifying the Predictive Role of Oxidative Stress Genes in the Prognosis of Glioma Patients
Di Lu12BCDE, Ning Yang12BEF, Shuai Wang12CDE, Wenyu Liu12CD, Di Zhang12AF, Jian Wang123AG, Bin Huang12AE, Xingang Li12AG*DOI: 10.12659/MSM.934161
Med Sci Monit 2021; 27:e934161
Table 2 Clinicopathological parameters of 686 glioma patients in the CGGA database.
Parameters | Cases | Proportion (%) |
---|---|---|
0–20 | 21 | 3.06 |
21–40 | 266 | 38.78 |
41–60 | 341 | 49.71 |
61–80 | 58 | 8.45 |
Male | 399 | 58.16 |
Female | 287 | 41.84 |
WHO II | 177 | 25.80 |
WHO III | 226 | 32.94 |
WHO IV | 283 | 41.25 |
A | 108 | 15.74 |
AA | 160 | 23.32 |
AO | 61 | 8.89 |
O | 74 | 10.79 |
GBM | 283 | 41.25 |
Primary | 442 | 64.43 |
Recurrent | 218 | 31.78 |
Secondary | 26 | 3.79 |
TMZ-treated | 501 | 73.03 |
Untreated | 185 | 26.97 |
Treated | 544 | 79.30 |
Untreated | 142 | 20.70 |
Mutant | 371 | 54.08 |
Wild-type | 315 | 45.92 |
Codeletion | 141 | 20.55 |
Non-codeletion | 545 | 79.45 |
Methylated | 386 | 56.27 |
Unmethylated | 300 | 43.73 |
GBM – glioblastoma multiforme; TMZ – temozolomide; WHO – World Health Organization. |